44 / 60
44
Scientific programme
Sunday, 31 May 2015
PL-4
Plenary Session
08:30–10:30
Clyde Auditorium
Controversies in ADHD
Chairs:
E. Taylor, United Kingdom
P. Riederer, Germany
PL-4-001 Are we facing a worldwide ADHD epi-
demic?
E. Taylor, United Kingdom
PL-4-002 Do prenatal environmental factors con-
tribute to the risk for ADHD?
D. Coghill, United Kingdom
PL-4-003 Is ADHD only a neurodevelopmental dis-
order?
G. Polanczyk, Brazil
PL-4-004 Should available pharmacogenetic tests
be used to inform clinicians on deciding
about treatment?
M. Bellgrove, Australia
10:30 – 11:00
Break
PL-5
Plenary Session
11:00–13:00
Clyde Auditorium
New advances in the treatment of ADHD
Chairs:
D. Coghill, United Kingdom
J. Thome, Germany
PL-5-001 Beyond stimulants and behaviour modi-
fication: New directions for treatment
development in ADHD: The next 20 years
J. Halperin, USA
PL-5-002 Cognitive behaviour therapy interventions
for adults with ADHD
M. Solanto, USA
PL-5-003 What future research should bring to help
resolving the debate about the efficacy
of EEG-neurofeedback in children with
ADHD?
J. Buitelaar, The Netherlands
PL-5-004 The potential role of transcranial magnetic
stimulation in the treatment of ADHD
R. Zaman, United Kingdom
Closing Ceremony
13:00–13:30
Clyde Auditorium
e
Congress summary
e
Presentation of best poster awards
e
Announcement of the
6
th
ADHD World Congress 2017